Related Experiment Video

Updated: Jun 13, 2026

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Correlates of valvular ossification in patients with aortic valve stenosis

Steven W Ing1, Emile R Mohler Iii, Mary E Putt

  • 1Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio, Pennsylvania, USA. Steven.Ing@osumc.edu

Clinical and Translational Science
|May 7, 2010
PubMed

Insights

Warfarin use and African American race are linked to higher odds of valvular ossification in patients with aortic stenosis. Further research is needed to confirm these findings and explore potential mechanisms.

Area of Science:

  • Cardiovascular Research
  • Bone Biology
  • Medical Pathology

Background:

  • Valvular calcification can involve active ossification, but its underlying causes remain largely unknown.
  • Understanding the determinants of valvular ossification is crucial for managing aortic stenosis.
  • This study investigates factors associated with bone formation in calcified aortic valves.

Purpose of the Study:

  • To identify subject and disease characteristics associated with valvular ossification.
  • To analyze risk factors for ossification in patients with calcified aortic valves.
  • To explore the relationship between valvular ossification and warfarin therapy or race.

Main Methods:

  • Retrospective review of medical records for 195 patients undergoing aortic valve excision.
  • Histopathological examination to identify valvular bone presence.
  • Statistical analyses (univariate and multivariate) to assess associations between patient characteristics and valvular ossification.

Main Results:

  • Warfarin therapy and African American race were independently associated with significantly increased odds of valvular ossification.
  • Factors like height and male sex showed univariate associations, while diabetes showed a trend towards lower odds.
  • No association was found between valvular ossification and ossification of costochondral cartilage.

Conclusions:

  • Warfarin use and African American race are significant risk factors for valvular ossification in patients with aortic stenosis.
  • Further investigation is warranted to confirm these associations and elucidate the role of matrix GLA protein inhibition by warfarin.
  • These findings may inform future therapeutic strategies for valvular calcification.

More Related Videos

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.